Hospitals report these codes with terse, inconsistent chargemaster text. This plain-English title was written by an AI model from that text and has not been reviewed by a person, so it can be wrong. The prices on this page come straight from hospital filings and do not depend on it.
Original text from hospital filings
CASIRIVIMABIMDEVIMAB (REGENCOV) (EUA) IVPB 600MG/1
Philadelphia, PA
See all hospitals reporting HCPCS Q0244 →Price type
Pennsylvania Hospital of the University of Pennsylvania Health System’s median price of $4 is 20900% above the median hospital's median price ($0), higher than 87% of the 554 hospitals reporting HCPCS Q0244. The highlighted bar is where this hospital falls; shaded is the middle 50% of hospitals.
Last updated: Mar 20, 2026
See Casirivimab and imdevimab 1200 mg infusion pricing across every hospital in the network reporting it, or ask Claude or any MCP client directly — see how to connect.